US stock screener and research workspace for self-directed investors
AI stock discovery built on SEC filings with daily catalysts and plain-English summaries
Stage
Not given
Not given
Founded
Not given
Not given
Based in
Not given
ES
Pricing model
Freemium
Freemium
Pricing
Free plan includes one complete introductory AI Mode run with six one-time credits. Premium includes two hundred credits per calendar month. Final subscription prices and billing terms are shown before payment.
Discovery tool: Free. API: Free (100 daily calls, attribution required); Builder €35.09/month or €350.90/year (EU prices incl. VAT); Pro €119.79/month or €1,197.90/year (EU prices incl. VAT).
Key features
Stock screening with customizable filters
Inspect financial statements and company filings
Valuation analysis with explicit assumptions
AI-assisted analysis and research support
Portfolio tools and saved workspaces
Dated price history and market data
Ownership records and fund holdings
Alerts and export functionality
Thesis workspace for documenting investment cases
Stock Sense MCP connector integration
Five-perspective scoring system (Fundamentals, Value, News flow, Momentum, Safety)
Discovery Gap measurement showing progress vs. market attention
Material 8-K event classification using language models
Monthly point-in-time snapshots never restated
Stock research API with JSON output
Company timeline of material events from filings
End-of-day market data integration
Filing alerts and company follow functionality
What makes it different
Combines dated public filings with current market prices and transparent calculations in one workspace
Emphasizes maintaining transparency about data freshness and source attribution
Designed specifically to help test investment theses with evidence-based research
Supports challenging investment assumptions with AI assistance checked against underlying sources
Public company research is open and accessible without requiring an account
Transparent methodology: all five scoring perspectives shown with sources and evidence
Public record of all calls, including mistakes, never restated monthly
Research, not investment advice or recommendations